Search research articles
Contact Us
Filters
Showing results (61-70 of 94) with videos related to
Page
of 10
Sort By:
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery
|
May 13, 2004
Lymphocyte subpopulations and cytokines in nasal polyps: is there a local immune system in the nasal polyp?
Joel M Bernstein, Mark Ballow, Gary Rich, et al.
Pediatrics
|
December 5, 2006
Initiation of maintenance antiinflammatory medication in asthmatic children in a pediatric emergency department
Heather K Lehman, Kathleen A Lillis, Steven H Shaha, et al.
Frontiers in Immunology
|
November 6, 2024
Contribution of immunoglobulin products in influencing seasonal influenza infection and severity in antibody immune deficiency patients receiving immunoglobulin replacement therapy
Mark Ballow, Raúl Ortiz-de-Lejarazu, Isabella Quinti, et al.
Journal of Clinical Immunology
|
May 2, 2018
Correction to: Assessment of Local Adverse Reactions to Subcutaneous Immunoglobulin (SCIG) in Clinical Trials
Mark Ballow, Richard L Wasserman, Stephen Jolles, et al.
Journal of Clinical Immunology
|
July 12, 2017
Assessment of Local Adverse Reactions to Subcutaneous Immunoglobulin (SCIG) in Clinical Trials
Mark Ballow, Richard L Wasserman, Stephen Jolles, et al.
American Journal of Rhinology
|
January 31, 2004
A superantigen hypothesis for the pathogenesis of chronic hyperplastic sinusitis with massive nasal polyposis
Joel M Bernstein, Mark Ballow, Patrick M Schlievert, et al.
The Journal of Allergy and Clinical Immunology
|
October 13, 2007
Images in immunodeficiency
William T Shearer, Charlotte Cunningham-Rundles, Mark Ballow, et al.
The Journal of Allergy and Clinical Immunology
|
June 30, 2012
Statement regarding "The public health benefits of air pollution control"
Dennis K Ledford, A Wesley Burks, Mark Ballow, et al.
Journal of Clinical Immunology
|
May 5, 2007
Carimune NF Liquid is a safe and effective immunoglobulin replacement therapy in patients with primary immunodeficiency diseases
Melvin Berger, Charlotte Cunningham-Rundles, Francisco A Bonilla, et al.
The Journal of Allergy and Clinical Immunology
|
October 16, 2007
Sublingual immunotherapy and subcutaneous immunotherapy: issues in the United States
Paul A Greenberger, Mark Ballow, Thomas B Casale, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 94) with videos related to
Sort By:
Page
of 10
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery
|
May 13, 2004
Lymphocyte subpopulations and cytokines in nasal polyps: is there a local immune system in the nasal polyp?
Joel M Bernstein, Mark Ballow, Gary Rich, et al.
Pediatrics
|
December 5, 2006
Initiation of maintenance antiinflammatory medication in asthmatic children in a pediatric emergency department
Heather K Lehman, Kathleen A Lillis, Steven H Shaha, et al.
Frontiers in Immunology
|
November 6, 2024
Contribution of immunoglobulin products in influencing seasonal influenza infection and severity in antibody immune deficiency patients receiving immunoglobulin replacement therapy
Mark Ballow, Raúl Ortiz-de-Lejarazu, Isabella Quinti, et al.
Journal of Clinical Immunology
|
May 2, 2018
Correction to: Assessment of Local Adverse Reactions to Subcutaneous Immunoglobulin (SCIG) in Clinical Trials
Mark Ballow, Richard L Wasserman, Stephen Jolles, et al.
Journal of Clinical Immunology
|
July 12, 2017
Assessment of Local Adverse Reactions to Subcutaneous Immunoglobulin (SCIG) in Clinical Trials
Mark Ballow, Richard L Wasserman, Stephen Jolles, et al.
American Journal of Rhinology
|
January 31, 2004
A superantigen hypothesis for the pathogenesis of chronic hyperplastic sinusitis with massive nasal polyposis
Joel M Bernstein, Mark Ballow, Patrick M Schlievert, et al.
The Journal of Allergy and Clinical Immunology
|
October 13, 2007
Images in immunodeficiency
William T Shearer, Charlotte Cunningham-Rundles, Mark Ballow, et al.
The Journal of Allergy and Clinical Immunology
|
June 30, 2012
Statement regarding "The public health benefits of air pollution control"
Dennis K Ledford, A Wesley Burks, Mark Ballow, et al.
Journal of Clinical Immunology
|
May 5, 2007
Carimune NF Liquid is a safe and effective immunoglobulin replacement therapy in patients with primary immunodeficiency diseases
Melvin Berger, Charlotte Cunningham-Rundles, Francisco A Bonilla, et al.
The Journal of Allergy and Clinical Immunology
|
October 16, 2007
Sublingual immunotherapy and subcutaneous immunotherapy: issues in the United States
Paul A Greenberger, Mark Ballow, Thomas B Casale, et al.
Page
of 10